Skymark Research Initiates Independent Research Coverage on Angiotech Pharmaceuticals, Inc.
04 Mai 2010 - 2:15PM
Skymark Research, a leading provider of small- and micro-cap
independent investment research, today initiated coverage on
Angiotech Pharmaceuticals, Inc. (Nasdaq:ANPI).
Skymark Research is currently offering a complimentary trial
subscription. To view our research go to:
www.skymarkresearch.com
About SMR:
Skymark Research is a leading provider of independent investment
research in North America. Our services include research
analysis on the small- and micro-cap markets, real-time news and
financial data, market commentary and the SMR newsletter. Skymark
Research's staff of small-cap investment professionals is dedicated
to providing the small market's investment community with the tools
and avenues necessary to make the important investment
decisions. To view our research reports on a complimentary
trial basis and take advantage of our other services, go to
www.skymarkresearch.com and click on the complimentary trial
subscription button on our home page, or go directly to our
registration page at www.skymarkresearch.com/signup.php.
The Skymark Research logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6683
About Angiotech Pharmaceuticals, Inc. (Nasdaq:ANPI)
Angiotech Pharmaceuticals, Inc. (Nasdaq:ANPI) is a specialty
pharmaceutical and medical device company that discovers, develops
and markets technologies primarily focused on acute and surgical
applications.
SMR Disclosure:
Skymarkresearch.com is not a registered investment advisor and
nothing contained in any materials should be construed as a
recommendation to buy or sell any securities. Skymark
Research has not been compensated by any of the above mentioned
companies. Please read our report and visit our Web site,
www.skymarkresearch.com, for complete risks and disclosures.
CONTACT: Skymark Research
Dylan Boyle
480-626-1911
info@skymarkresearch.com
![Skymark Research](http://media.primezone.com/cache/11694/small/7418.jpg)
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2024 bis Aug 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Aug 2023 bis Aug 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere News-Artikel